Average Co-Inventor Count = 6.89
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (20 from 212 patents)
2. Merck Frosst Canada & Co. (6 from 80 patents)
3. Merck Sharp + Dohme Corp. (3 from 2,405 patents)
4. Merck Canada Inc. (2 from 40 patents)
29 patents:
1. 9586931 - Triazolyl derivatives as Syk inhibitors
2. 9242984 - Pyrazolyl derivatives as Syk inhibitors
3. 7960409 - Pharmaceutical phenylquinoline and chromen-2-one triazole compounds
4. 7943649 - 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
5. 7442716 - 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
6. 6841564 - Tri-aryl-substituted-ethane PDE4 inhibitors
7. 6639077 - Tri-aryl-substituted-ethane PDE4 inhibitors
8. 6486194 - Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
9. 6448274 - Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor
10. 6399636 - Tri-aryl-substituted-ethane PDE4 inhibitors
11. 6316472 - Heterosubstituted pyridine derivatives as PDE 4 inhibitors
12. 6200993 - Heterosubstituted pyridine derivatives as PDE4 inhibitors
13. 5840746 - Use of inhibitors of cyclooxygenase in the treatment of
14. 5710160 - Diphenyl pyridyl ethane derivatives as PDE IV inhibitors
15. 5710140 - Phenyl heterocycles as COX-2 inhibitors